No funding or sponsorship was received for this study or publication of this article.
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Kamal S. Saini conceptualized the manuscript; all authors provided significant inputs; Kamal S. Saini wrote the manuscript; all authors reviewed, edited, and approved the final manuscript.
Kamal S. Saini reports consulting fees from the European Commission outside the submitted work.
Diogo Martins-Branco declares honoraria and advisory board fees from Janssen, Pfizer, Merck Sharp & Dohme, Angelini, AstraZeneca, and Novartis, and meeting/travel grants from LEO Farmacêuticos, Merck Sharp & Dohme, Ipsen, Janssen, Roche, Laboratórios Vitória, and Novartis, outside the submitted work.
Marco Tagliamento declares travel, accommodations, expenses supported by Roche, Bristol-Myers Squibb, AstraZeneca, and Takeda, and activity as medical writer supported by Novartis and Amgen outside the submitted work.
Kevin Punie reports honoraria for advisory/consultancy roles for AstraZeneca, Eli Lilly, Gilead Sciences, Novartis, Pfizer, Pierre Fabre, Hoffmann/La Roche and Vifor Pharma (paid to institution, outside the submitted work); speaker fees for Eli Lilly, Medscape, MSD, Mundi Pharma, Novartis, Pfizer and Hoffmann/La Roche (paid to institution, outside the submitted work); research funding from Sanofi (paid to institution, outside the submitted work); and travel support from AstraZeneca, Novartis, Pfizer, PharmaMar, and Hoffmann/La Roche outside the submitted work.
Giuseppe Curigliano reports personal fees for consulting, advisory role, and speakers’ bureau from Roche/Genentech, Novartis, Pfizer, Lilly, Foundation Medicine, Samsung, and Daichii-Sankyo; honoraria from Ellipses Pharma; and fees for travel and accommodation from Roche/Genentech, and Pfizer outside the submitted work.
Evandro de Azambuja reports honoraria and advisory board fees from Roche/GNE, Novartis, Seattle Genetics, Eli Lilly, Zodiacs, Libbs, and Pierre Fabre; travel grants from Roche/GNE, GSK, and Novartis; and research grants to institution from Roche/GNE, AstraZeneca, GSK, Novartis, and Servier outside the submitted work.
Matteo Lambertini acted as consultant for Roche, Lilly, AstraZeneca, and Novartis, and received speaker honoraria from Roche, Takeda, Lilly, Novartis, Pfizer, and Sandoz outside the submitted work.
The other authors do not report any conflicts of interest.
Compliance with ethics guidelines
This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
Consent to publish
All authors have reviewed the final version of this manuscript and provided their consent to publish.
All data and references mentioned in this manuscript are from publicly available sources. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.